Projects related to 6-2009-2241

Results Found (27)
Technology NameBriefcaseLead Researcher
  Background Current methods of tissue fixation leave much to be desired, essentially relying on technologies developed from the clothing and carpentry industries i.e. sutures, screws, and pins. Bioadhesives offer a less traumatic method of ...
More
Mandler Daniel
Background Most active pharmaceutical ingredients (APIs) are not suitable for “passive” loading into nano-liposomes. The desired concentration in the nano-liposomes is hard to achieve. Consequently, the therapeutic efficacy in humans is not ...
More
Goldblum Amiram
Background Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces Neuropeptides are potent CNS neuromodulators and have many ...
More
Domb Abraham
  Additional information will be provided upon request
More
Domb Abraham
Background  Micro-emulsions are formed more or less spontaneously when their components are brought into contact.  They have been the only successful delivery systems for certain types of pharmaceutical compounds, particularly compounds such as ...
More
Domb Abraham
  Additional information will be provided upon request
More
Domb Abraham
Category Life Sciences and Bio Technology    Keywords Chemotherapy, Drug resistance * The project is conducted in collaboration with Memorial Sloan-Kettering Cancer Center. Application Cells with multidrug resistance (MDR) due to aberrant ...
More
Barenholz Yechezkel
Background Peptides are key players in a variety of physiological and pathological processes and play very important roles in modulating various cell functions. One of the most important challenges developing peptide drugs is the lack of ...
More
Gilon Chaim
Category Life Sciences and Biotechnology    Keywords Anorexia nervosa, sustained release, low dose approved drug patient compliance Current development stage For Pharmaceutical development: TRL4 - PoC&Safety of candidate device or ...
More
Avraham Yosefa
Category Agriculture Keywords Anti Biofilm, Biological Control, Controlled Release, Environmentally Friendly Current development stage General list: TRL2  Technology Concept Formulated          Collaboration Opportunity Sponsored Research ...
More
Nussinovitch Amos
Category Prolonged release oral tablets    Keywords Cannabinoids, Cannabis, tablets, oral administration  Application In recent years, the medical use of cannabis and its derivatives has become widely accepted in the medical profession.  IN ...
More
Friedman Michael
  Category Life Sciences and Biotechnology    Keywords autism, treatment Current development stage For Pharmaceutical development: TRL4 - PoC&Safety of candidate device or system is demonstrated in a defined lab or animal ...
More
Amal Haitham
Background Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) are leading causes of blindness in the Western world. Both are characterized by pathological angiogenesis in the various eye structures. With high prevalence  in  ...
More
Willner Itamar
  Additional information will be provided upon request
More
Domb Abraham
Background Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces Neuropeptides are potent CNS neuromodulators and have many ...
More
Domb Abraham
Background The release of targeted drugs is often achieved by attaching the drug load to a carrier through specific peptide sequences which are cleaved by proteases that are highly expressed at the desired location. Cathepsins proteases, ...
More
Blum Galia
Background Multiple strategies exist for the targeted treatment of different cell pathologies. One ongoing challenge is the introduction of therapeutic molecules into cells. Current approaches rely on viral vectors, electroporation, or carriers. ...
More
Shenhar Roy
Categories: Life Science & Biotechnology Technology Keywords: Nasal administration, CNS active oil,  neurodegenerative diseases, CNS Development Stage: Formulation and experiments in animals Patent Status: US  patent application ...
More
Touitou Elka
Background The physical size of protein drugs and their susceptibility to degradation are key determinates that make them more dependent on drug delivery technologies. However formulating protein delivery systems so that they maintain their ...
More
Barenholz Yechezkel
  Current Development Stage TRL 9 Ready for mass production   Our Innovation Pouch drug delivery system (web- like films) for dermal, transdermal and nail  administration of drugs and actives for various treatments Applied to the nail or ...
More
Touitou Elka
  Categories Cannabinoid Administration, Formulation, Drug Delivery, Novel Carriers, Transdermal Formulation, Nasal Formulation, Oral formulation Development Stage In-vivo proof of concept Patent Status Several patent applications – new ...
More
Touitou Elka
BackgroundAccording to the World Health Organization approximately 422 million people currently suffer from diabetes. Type-I diabetes patients are characterized by their pancreas β-cells dysfunction and thereby absence of insulin secretion. ...
More
Willner Itamar